GlassScriptPhysician profile
Raymond C Hui
NPI 1699865618
$3,472.60
in general payments reported to CMS, 2019-2025
14 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,599 · 2020: $352 · 2021: $349 · 2022: $391 · 2023: $283 · 2024: $313 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $780.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $903.08 | 2019-2024 | Repatha |
| Amarin Pharma, INC. | $802.34 | 2019-2022 | |
| Lilly USA, LLC | $439.23 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $396.11 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $266.18 | 2021-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.81 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $117.93 | 2024-2025 | Trelegy Ellipta |
| Lundbeck LLC | $80.18 | 2019 | |
| Novo Nordisk INC | $63.37 | 2021-2023 | Ozempic |
| Aurinia Pharma U.S., INC. | $39.36 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $38.47 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.94 | 2019 | |
| Allergan, INC. | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Hui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.